Loading
Latest filing published 22 Jun 2026 for RESTART LIFE SCIENCES CORP..
No signal scores available.
This profile gathers the share dealings of Lindsay Hamelin in Restart Life Sciences Corp. We count 2 filings, every one of them for a trade on 18 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 22 June 2026 with a share grant in Restart Life Sciences Corp. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations